Analysis of the level of polypharmacy in patients from an isolated rural area: effect of age, sex, and chronic diseases
- PMID: 40556639
- PMCID: PMC12185413
- DOI: 10.3389/fdgth.2025.1508505
Analysis of the level of polypharmacy in patients from an isolated rural area: effect of age, sex, and chronic diseases
Abstract
Introduction: The increase in life expectancy and the greater number of chronic diseases have led to a greater use of medications. This polypharmacy can cause a greater number of drug-related problems and negative results on the patient's health associated with medication, which is why most health services are focused on solving these problems. Machine learning uses different techniques to generate knowledge in health, one of them is regression, whose model establishes that a prognosis is created from a dependent variable and a series of independent variables.
Materials and methods: Data collection was conducted during 2021-2022 in an isolated rural pharmacy. The screening of participants susceptible to being part of the study began at the time of dispensing, verifying that they were part of the personalized dosing system (PDS) service.
Results: The study population consisted of 78 participants, predominantly female. The sociodemographic profile was characterized by being female, between 66 and 80 years of age. The number of chronic diseases per participant was 4.25 ± 1.49. During the study phase, a total of 450 drug-related problems (DRPs) were detected, with an average of 5.64 ± 2.69 DRPs per participant.
Discussion: Age and the assigned polypharmacy level are the factors that most influence the final polypharmacy level. However, it is necessary to include the variable "chronic diseases" since in some situations it seems to be significant.
Conclusion: The factors that most influence the polypharmacy index are patient age and initial polypharmacy level and, to a lesser extent, but no less important, the number of chronic diseases.
Keywords: DRP; NOM; polypharmacy; rural area; safety.
© 2025 Abdala Kuri, Morales, Oliva, Peña and Dévora.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930
References
-
- Zhuzhingo Vásquez CJ, Torres-Jaramillo I, Tacuri-Romero JN, Bastidas Riofrío JL, Huailas Suquilanda WA, Jaramillo Chica DA. Perception of the multi-pathological elderly patient in the face of polypharmacy. Psic UNEMI. (2019) 3(5):34–41.
LinkOut - more resources
Full Text Sources
Miscellaneous